Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Henderson

Showing results (521-530 of 547) with videos related to

Pageof 55
Sort By:
Annals of the American Thoracic Society|May 3, 2021
Respiratory Impacts of Wildland Fire Smoke: Future Challenges and Policy Opportunities. An Official American Thoracic Society Workshop ReportMary B Rice, Sarah B Henderson, Allison A Lambert, et al.
Journal of Medical Genetics|October 13, 2023
Intellectual disability syndrome associated with a homozygous founder variant in <i>SGSM3</i> in Ashkenazi JewsRivka Birnbaum, Shlomit Ezer, Nava Shaul Lotan, et al.
Journal of Medical Genetics|September 4, 2017
Missense variants in the chromatin remodeler <i>CHD1</i> are associated with neurodevelopmental disabilityGenay O Pilarowski, Hilary J Vernon, Carolyn D Applegate, et al.
Lancet (London, England)|June 19, 2018
Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trialGemma D Banham, Shaun M Flint, Nicholas Torpey, et al.
HGG Advances|April 12, 2025
Homozygous variants in EIF3K associated with neurodevelopmental delay, microcephaly, and growth retardationBobbi McGivern, Tess Holling, Maria J Guillen Sacoto, et al.
Annals of Neurology|March 9, 2018
Recessive mutations in VPS13D cause childhood onset movement disordersJulie Gauthier, Inge A Meijer, Davor Lessel, et al.
Annals of the Rheumatic Diseases|August 19, 2024
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE studyCynthia Aranow, Cornelia F Allaart, Zahir Amoura, et al.
Human Reproduction (Oxford, England)|March 20, 2013
Replication of genetic loci for ages at menarche and menopause in the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) studyC L Carty, K L Spencer, V W Setiawan, et al.
BMC Cancer|April 9, 2024
Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcomaArash O Naghavi, J M Bryant, Youngchul Kim, et al.
Nature|February 27, 2009
Identification of IFRD1 as a modifier gene for cystic fibrosis lung diseaseYuanYuan Gu, Isaac T W Harley, Lindsay B Henderson, et al.
Pageof 55

Showing results (521-530 of 547) with videos related to

Sort By:
Pageof 55
Annals of the American Thoracic Society|May 3, 2021
Respiratory Impacts of Wildland Fire Smoke: Future Challenges and Policy Opportunities. An Official American Thoracic Society Workshop ReportMary B Rice, Sarah B Henderson, Allison A Lambert, et al.
Journal of Medical Genetics|October 13, 2023
Intellectual disability syndrome associated with a homozygous founder variant in <i>SGSM3</i> in Ashkenazi JewsRivka Birnbaum, Shlomit Ezer, Nava Shaul Lotan, et al.
Journal of Medical Genetics|September 4, 2017
Missense variants in the chromatin remodeler <i>CHD1</i> are associated with neurodevelopmental disabilityGenay O Pilarowski, Hilary J Vernon, Carolyn D Applegate, et al.
Lancet (London, England)|June 19, 2018
Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trialGemma D Banham, Shaun M Flint, Nicholas Torpey, et al.
HGG Advances|April 12, 2025
Homozygous variants in EIF3K associated with neurodevelopmental delay, microcephaly, and growth retardationBobbi McGivern, Tess Holling, Maria J Guillen Sacoto, et al.
Annals of Neurology|March 9, 2018
Recessive mutations in VPS13D cause childhood onset movement disordersJulie Gauthier, Inge A Meijer, Davor Lessel, et al.
Annals of the Rheumatic Diseases|August 19, 2024
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE studyCynthia Aranow, Cornelia F Allaart, Zahir Amoura, et al.
Human Reproduction (Oxford, England)|March 20, 2013
Replication of genetic loci for ages at menarche and menopause in the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) studyC L Carty, K L Spencer, V W Setiawan, et al.
BMC Cancer|April 9, 2024
Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcomaArash O Naghavi, J M Bryant, Youngchul Kim, et al.
Nature|February 27, 2009
Identification of IFRD1 as a modifier gene for cystic fibrosis lung diseaseYuanYuan Gu, Isaac T W Harley, Lindsay B Henderson, et al.
Pageof 55